Feed PRME
PR
Prime Medicine, Inc.
PRME · NASDAQ
$3.17 +3.43% (+$0.10)
1M +3.93%
Market Cap $572.6M
P/E Ratio -
Div. Yield -
ROE 188.82%
Piotroski F-Score Weak
2/9Valuation
4 /100
Expensive P/B 7.46x
P/S 141.93x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 27.43%
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Net margin 4,917.55%
Op. margin 5,121.77%
FCF margin 3,935.05%
Quality
0 /100
Poor ROE 188.82%
ROA 67.31%
Asset turnover 0.01x
Debt
57 /100
Moderate Current ratio 3.80x
Debt/Equity 1.49x
Net debt/EBITDA N/A
Stability
22 /100
Unstable EPS volatility 40.70%
Profitable years 0
Beta 2.31x
Întreabă StockBot despre PRME
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Allan Reine
Employees
146
Headquarters
Cambridge
Evenimente viitoare
06 NOV.
Earnings
Upcoming earnings report